Rune is poised to develop six novel treatments as First-in-Class, uniquely differentiated products. We have two further products as treatments for ADHD and Migraine/Pain which will be initiated once further licensing takes place.
We are active in the areas of Depression, Sexual Dysfunction, Psychoses/MDD, Anxiety, Hostility and Dementia/PD.
Our pipeline is as follows:
